Opportunity Information: Apply for PA 09 133

  • The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
  • This funding opportunity was created on Mar 17, 2009 and posted on Mar 17, 2009.
  • Applicants must submit their applications by May 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts City or township governments State governments County governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PA 09 133

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21) opportunity (Funding Opportunity Number PA 09 133) is a National Institutes of Health discretionary grant program led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in partnership with the NIH Office of Dietary Supplements (ODS). Its main goal is to support early stage, exploratory clinical research that could meaningfully improve how diabetes, obesity, endocrine disorders, and genetic metabolic diseases are prevented or treated. The focus is on short term clinical studies that let investigators test fresh ideas quickly, without the heavy expectation of extensive preliminary data that is typical for larger clinical trials and later stage awards. In practical terms, this funding is meant to help researchers find out whether a new clinical concept is workable and promising enough to justify bigger, more definitive studies later on.

A central theme of the program is “pilot and feasibility” work: small, carefully designed clinical projects that answer high impact questions and reduce uncertainty. The announcement specifically highlights studies that test new prevention strategies, new interventions, or novel combinations of therapies. Another major priority is translation, meaning the program is particularly interested in helping move strong laboratory or preclinical discoveries into real world clinical testing. The scope explicitly spans diabetes and endocrine diseases as well as genetic metabolic diseases, and it also notes cystic fibrosis within that broader set of conditions, reflecting the program’s interest in metabolic and endocrine complications across disease areas.

The mechanism used is the NIH Exploratory/Developmental grant mechanism (R21). R21 awards are generally structured to fund early, concept testing work rather than large scale validation, which fits the stated goal of enabling short, targeted clinical studies. The notice lists an award ceiling of $200,000, signaling that projects should be scoped accordingly, with realistic milestones that can be achieved within an exploratory budget. At the same time, the announcement makes clear that the exact size, duration, total dollars awarded, and number of awards are not fixed in advance. Instead, those outcomes depend on the volume of applications received and, most importantly, the quality, cost, and proposed duration of the applications that are submitted and deemed meritorious.

Eligibility is broad and includes many types of domestic and non domestic organizations. Eligible applicants include public and state controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for profit organizations (including small businesses and other than small businesses), and a wide range of governmental entities such as state, county, city or township governments, special district governments, and independent school districts. The program also welcomes applications from Native American tribal governments (both federally recognized and other than federally recognized) and tribal organizations, tribally controlled colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), faith based or community based organizations, regional organizations, U.S. territories or possessions, and even foreign organizations (non U.S. entities). The listing also notes that eligible agencies of the federal government may apply. There is no cost sharing or matching requirement, which lowers the barrier to participation for organizations that may not have discretionary funds to contribute.

In terms of administrative details, the opportunity falls under the “Food and Nutrition” and “Health” activity categories and is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). The announcement was posted and created on March 17, 2009, with an original closing date of May 7, 2012 and the same current closing date listed, after which it was archived on June 7, 2012. While it is an archived opportunity and not an active application window today, the summary still reflects the program’s intent: to provide a relatively fast, flexible funding path for early clinical testing that could open the door to larger clinical trials and, ultimately, changes in clinical practice for diabetes, obesity, and endocrine and metabolic diseases.

For applicants or readers who need the full text, the announcement points to the NIH Grants Guide link (http://grants.nih.gov/grants/guide/pa-files/PA-09-133.html). For technical access issues, it directs inquiries to the NIH Office of Extramural Research (OER) webmaster via FBOWebmaster@OD.NIH.GOV.

Frequently Asked Questions (FAQs)

What is the Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21) opportunity?

It is an NIH discretionary grant opportunity (Funding Opportunity Number PA 09 133) designed to support early-stage, exploratory clinical research related to diabetes, obesity, endocrine disorders, and genetic metabolic diseases. The program emphasizes pilot and feasibility clinical studies that can quickly test new ideas and determine whether they are promising enough for larger, definitive studies later.

Which NIH institute leads this funding opportunity?

The program is led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in partnership with the NIH Office of Dietary Supplements (ODS).

What is the primary goal of this program?

The main goal is to support short-term, exploratory clinical research that could meaningfully improve how diabetes, obesity, endocrine disorders, and genetic metabolic diseases are prevented or treated. The intent is to reduce uncertainty and establish whether a clinical concept is workable and worth pursuing in larger studies.

What does "pilot and feasibility" mean in this context?

In this program, "pilot and feasibility" refers to small, carefully designed clinical projects that answer high-impact questions and test whether an approach is practical and promising. These studies are intended to be focused and exploratory rather than large-scale confirmatory trials.

What kinds of studies are highlighted as priorities?

The announcement specifically highlights short-term clinical studies that test new prevention strategies, new interventions, or novel combinations of therapies. It also emphasizes translation, meaning moving strong laboratory or preclinical discoveries into real-world clinical testing.

Is this program intended for large clinical trials?

No. The R21 mechanism is aimed at early, concept-testing work rather than large-scale validation. The opportunity is framed around short, targeted clinical studies rather than extensive, later-stage clinical trials.

What NIH grant mechanism is used for this opportunity?

The opportunity uses the NIH Exploratory/Developmental grant mechanism (R21).

How much funding is available per award?

The notice lists an award ceiling of $200,000, signaling that proposed projects should be scoped to fit an exploratory budget with realistic milestones.

Are the award amount, project duration, or number of awards fixed in advance?

No. The announcement states that the exact size, duration, total dollars awarded, and number of awards are not predetermined. These depend on factors such as the number of applications received and the quality, cost, and proposed duration of the meritorious applications.

What disease areas are within scope?

The scope spans diabetes and endocrine diseases as well as genetic metabolic diseases. The announcement also notes cystic fibrosis within this broader set of conditions, reflecting interest in metabolic and endocrine complications across disease areas.

Is translational research encouraged?

Yes. A major priority is translation, with particular interest in moving laboratory or preclinical discoveries into clinical testing.

What types of organizations are eligible to apply?

Eligibility is broad and includes many types of domestic and non-domestic organizations. Examples listed include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (including small businesses and other than small businesses), and a wide range of governmental entities.

Are state and local government entities eligible?

Yes. The opportunity lists state governments, county governments, city or township governments, special district governments, and independent school districts among eligible applicants.

Are tribal governments and tribal organizations eligible?

Yes. The listing includes Native American tribal governments (both federally recognized and other than federally recognized) and tribal organizations, as well as tribally controlled colleges and universities.

Are minority-serving institutions specifically included?

Yes. The eligibility list explicitly mentions Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, and Historically Black Colleges and Universities (HBCUs).

Can faith-based or community-based organizations apply?

Yes. Faith-based or community-based organizations are explicitly included in the eligibility list.

Are U.S. territories or possessions included as eligible applicants?

Yes. The eligibility list includes U.S. territories or possessions.

Are foreign (non-U.S.) organizations eligible to apply?

Yes. The announcement indicates that foreign organizations (non-U.S. entities) are eligible applicants.

Can U.S. federal government agencies apply?

Yes. The listing notes that eligible agencies of the federal government may apply.

Is cost sharing or a matching contribution required?

No. The opportunity states there is no cost sharing or matching requirement.

What activity categories is this opportunity associated with?

The opportunity falls under the "Food and Nutrition" and "Health" activity categories.

What CFDA number is associated with this program?

The opportunity is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).

When was this funding opportunity posted, and what were the closing dates?

The announcement was posted/created on March 17, 2009. The original closing date was May 7, 2012, and the same date is listed as the current closing date in the summary. The opportunity was archived on June 7, 2012.

Is this opportunity still open for applications?

Based on the provided information, it is an archived opportunity and is not an active application window today. The listed closing date is May 7, 2012, and it was archived on June 7, 2012.

Where can applicants find the full funding announcement text?

The announcement points to the NIH Grants Guide: http://grants.nih.gov/grants/guide/pa-files/PA-09-133.html

Who should be contacted for technical access issues related to the announcement?

For technical access issues, inquiries are directed to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more business programs for Diabetes Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Technological Innovation and Cooperation for Foreign Information Access Program CFDA 84.337A

Previous opportunity: Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 09 133

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 09 133) also looked into and applied for these:

Funding Opportunity
Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 09 005

Funding Number: RFA DK 09 005
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Renal Function and Chronic Kidney Disease in Aging (R01) Apply for PA 09 165

Funding Number: PA 09 165
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Nutrition Obesity Research Centers (P30) Apply for RFA DK 09 006

Funding Number: RFA DK 09 006
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Non Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases and Hypertensive Disorders (R01) Apply for PA 09 181

Funding Number: PA 09 181
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) Apply for PA 09 196

Funding Number: PA 09 196
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Advances in Polycystic Kidney Disease (R01) Apply for PA 09 202

Funding Number: PA 09 202
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
NIDDK Small Grants for Clinical Scientists to Promote Diversity in Health Related Research (R03) Apply for PAR 09 223

Funding Number: PAR 09 223
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $125,000
Public Private Alliances Related to Nutrition in Peru Apply for M OAA GRO EGAS 09 232 HPERU

Funding Number: M OAA GRO EGAS 09 232 HPERU
Agency: Agency for International Development
Category: Food and Nutrition Health
Funding Amount: $1,500,000
Calcium Oxalate Stone Diseases (R01) Apply for PA 09 213

Funding Number: PA 09 213
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Consortium of Food Allergy Research (CoFAR) and CoFAR Statistical and Clinical Coordinating Center (CoFAR SACCC) (U19 and U01) Apply for RFA AI 09 039

Funding Number: RFA AI 09 039
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) Apply for PAR 09 230

Funding Number: PAR 09 230
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $50,000
Cystic Fibrosis Research and Translation Core Centers (P30) Apply for RFA DK 09 009

Funding Number: RFA DK 09 009
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) Apply for PAR 09 247

Funding Number: PAR 09 247
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Pilot Studies for Studying the Mechanisms of Improvement in Type 2 Diabetes and Cardiovascular Risk Factors or in Cardiovascular, Lung, or Sleep Diseases after Bariatric Surgery (R01) Apply for RFA DK 09 012

Funding Number: RFA DK 09 012
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $400,000
Beta Cell Biology Consortium (U01) Apply for RFA DK 09 011

Funding Number: RFA DK 09 011
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition for Continuation of the Randomized Intervention for Vesicoureteral Reflux (RIVUR) (U01) Apply for RFA DK 09 502

Funding Number: RFA DK 09 502
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition Clinical Centers and Data Coordinating Center for the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Trial (U01) Apply for RFA DK 09 503

Funding Number: RFA DK 09 503
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition Coordinating Center For The Beta Cell Biology Consortium (U01) Apply for RFA DK 09 504

Funding Number: RFA DK 09 504
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Stimulating Hematology Investigation New Endeavors (SHINE) (R01) Apply for PAS 10 046

Funding Number: PAS 10 046
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Human Brown Adipose Tissue Methods for Measurement of Mass and Activity (R21) Apply for RFA DK 10 002

Funding Number: RFA DK 10 002
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 133", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.